New Delhi: Bharat Biotech on Wednesday said its coronavirus vaccine Covaxin has shown efficacy of 78 per cent against mild, moderate and severe cases of COVID-19, as per Phase III interim analysis results. The vaccine maker noted that the second interim data of the Phase III study also showed that chances of hospitalisation due to the […]
